Udhayvir Grewal։ Bridging the Gap in Chemotherapy-Induced Thrombocytopenia
Udhayvir Grewal, GI Oncologist at Winship Cancer Institute of Emory University, shared a post on X about a recent article he and his colleagues co-authored, published in Journal of Clinical Oncology, adding:
” Hot off the press! Enjoyed writing this commissioned piece ‘Bridging the Gap’ in JCO ASCO on the role of thrombopoeitin receptor agonists for the management of chemotherapy induced thrombocytopenia in GI malignancies; with (a commentary on the recently published ACT-GI trial).
We propose a three dimensional framework to guide patient selection.”
Title: Bridging the Gap: Clinical Integration of Thrombopoietin Receptor Agonists in GI Cancer–Associated Chemotherapy-Induced Thrombocytopenia
Authors: Raafat S. Alameddine, Timothy J. Brown, Nicholas J. Hornstein, Udhayvir S. Grewal
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 23, 2026, 16:05Platelet Secretion Defects and Their Role in the Diagnosis of Bleeding Disorders
-
Oct 23, 2026, 16:00Hemophilia Alliance team in New Orleans at the ATHN Data Summit
-
Oct 23, 2026, 15:49Brian Sapp: Why Exact Calf Vein Naming Is Critical for DVT Diagnosis?
-
Oct 23, 2026, 15:33Smitirupa Mishra: A Systematic Approach to Bone Marrow Examination
-
Oct 23, 2026, 15:29José Antonio García Erce: Preoperative Anemia Emerges as a Modifiable Surgical Risk in New POWER Study
-
Oct 23, 2026, 15:13Reza Shojaei: Manufactured Red Blood Cells vs Blood Donation
-
Oct 23, 2026, 14:29Jean Jacques Kiladjian: International Scientific Exchange at IHCAMS in Tianjin
-
Oct 23, 2026, 14:11Aravind Palraj: The Prolonged aPTT Puzzle in SLE
-
Oct 23, 2026, 13:56Chokri Ben Lamine: The Evolving Treatment Landscape of Persistent and Chronic ITP